CapsoVision, Inc.

US$6.32As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CVHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (335.06%)
Medical Devices
Beta (5Y) —
PE TTM —
TSR TTM 29.51%
Mkt cap US$316.3M
ROIC (181.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.92
25.31%
121.92%
Hold 1|2|4|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.14
0.15
0.15
20.80%
23.54%
25.13%
21.45%
Revenue$M
23.97
24.91
25.28
26.47
18.41%
17.35%
13.10%
15.33%
Peers (US$316.3M)
Cap (US$)
PE
315.3M
—
321.2M
25.74x
Capital
TTM
5Y
10Y
Leveragex
2.523
(0.181)
(0.159)
EBIT/Intx
14.27
0.130
0.127
Own earn%
(71.87)
21.75
17.10
Sh yield%
27.62
18.95
23.07
Owners
Insiders/Inst%
2.15
57.04
Short interest%
4.52
SBC / revenue%
1.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
29–37
$1 testx
—
Incr. ROIC%
15